Balyasny Asset Management

Balyasny Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Balyasny Asset Management’s Portfolio AMPH Stock Details AMPH Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$3.78M	Sell
2025 Q2	$6.11M	Buy
2025 Q1	$4.7M	Buy
2023 Q3	–	Sell
2023 Q2	$526K	Buy